Compatibility of the antitumoral β-lapachone with different solid dosage forms excipients

Journal of Pharmaceutical and Biomedical Analysis

Volumn 45, Issue 4, 2007, Pages 590-598

  Cunha Filho, Marcílio S S ^a   Martínez Pacheco, Ramón ^a   Landín, Mariana ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Lapachone; Compatibility; Differential scanning calorimetry; Excipient

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA LAPACHONE; CALCIUM PHOSPHATE DIBASIC; DILUENT; DISINTEGRATING AGENT; EXCIPIENT; FUMARIC ACID DERIVATIVE; LUBRICATING AGENT; MAGNESIUM STEARATE; MANNITOL; METHYL BETA CYCLODEXTRIN; SOLUBILIZER; STEARYL FUMARATE SODIUM; UNCLASSIFIED DRUG;

ARTICLE; COOLING; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; ENTHALPY; EVALUATION; HEATING; INFRARED SPECTROSCOPY; MICROSCOPY; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALORIMETRY, DIFFERENTIAL SCANNING; DOSAGE FORMS; DRUG INTERACTIONS; EXCIPIENTS; MICROSCOPY, VIDEO; NAPHTHOQUINONES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 35548987490     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.08.016     Document Type: Article

References (28)

1. Burnett A.R., and Thomson R.H. J. Chem. Soc. C 7 (1968) 850-853
2. Hooker S.C., Shepard H.W., Walsh Jr. J.G., and Connitt G.H. J. Am. Chem. Soc. 58 (1936) 90-1197
3. Li C.J., Wang C., and Pardee A.B. Cancer Res. 55 (1995) 3712-3715
4. Planchon M., Wuerzberger S., Frydman B., Witiak D.T., Hutson P., Church D.R., Wilding G., and Boothman D.A. Cancer Res. 55 (1995) 3706-3711
5. Ough M., Lewis A., Bey E.A., Gao J., Ritchie J.M., Bornmann W., Boothman D.A., Oberley L.W., and Cullen J.J. Cancer. Biol. Ther. 4 (2005) 95-102
6. Damien G. STP Pharma Pratiques 14 (2004) 303-310
7. Verma R.K., and Garg S. J. Pharm. Biomed. Anal. 38 (2005) 633-644
8. Kiss D., Zelko R., Novak C., and Ehen Z. Therm. Anal. Calorim. 84 (2006) 447-451
9. Mora P.C., Cirri M., and Mura P. J. Pharm. Biomed. Anal. 42 (2006) 3-10
10. Nasongkla N., Wiedmann A.F., Bruening A., Beman M., Ray D., Bornmann W.G., Boothman D.A., and Gao J. Pharm. Res. 20 (2003) 1626-1633
11. Wang F., Blanco E., Ai H., Boothman D.A., and Gao J. J. Pharm. Sci. 95 (2006) 2309-2319
12. Cunha-Filho M., Dacunha-Marinho B., Torres-Labandeira J.J., Martínez-Pacheco R., and Landín M. AAPS Pharm. Sci. Technol. 8 (2007) 10.1208/pt0803060 Article 60
13. Nyqvist H. Int. J. Pharm. Technol. Prod. 4 (1983) 47-48
14. Bugay D.E., and Findlay W.P. Pharmaceuticasl Excipients: By IR, Raman, and NMR Spectroscopy (1999), Marcel Dekker, New York 669 p
15. Wells J. Pharmaceutical Preformulation (1988), Ellis Horwood, Chichester 227 p
16. American Pharmaceutical Association. Handbook of Pharmaceutical Excipients. 4th ed. (2006), Pharmaceutical Press, London 918 p
17. Sawicka J. Pharmazie 46 (1991) 519-521
18. Hassan M.A., Kaloustian J., Prinderre P., Ramsis H., Khaled K.A., El-Faham T.H., Tous S.S., Maury L., and Joachim J. Pharmazie 51 (1996) 400-403
19. Tomassetti M., Catalani A., Rossi V., and Vecchio S. J. Pharm. Biomed. Anal. 37 (2005) 949-955
20. Landín M., Martínez-Pacheco R., Gómez-Amoza J.L., Souto C., Concheiro A., and Rowe R.C. Int. J. Pharm. 103 (1994) 9-18
21. Landín M., Rowe R.C., and York P. Int. J. Pharm. 104 (1994) 271-275
22. Pyramides G., Robinson J.W., and Zito S.W. J. Pharm. Biomed. Anal. 13 (1995) 103-110
23. Oliveira G.G., Ferraz H.G., and Matos J.S.R. Therm. Anal. Calorim. 79 (2005) 267-270
24. Marini A., Berbenni V., Moioli S., Bruni G., Cofrancesco P., Margheritis C., and Villa M. Therm. Anal. Calorim. 73 (2003) 529-545
25. Verma R.K., and Garg S. J. Pharm. Biomed. Anal. 35 (2004) 449-458
26. Malan C.E., Villiers M.M., and Lotter A.P. J. Pharm. Biomed. Anal. 15 (1997) 549-557
27. Davis M.E., and Brewster M.E. Nat. Rev. Drug Discov. 12 (2004) 1023-1035
28. Landín M., Fontao M.J., and Martinez-Pacheco R. Drug Dev. Ind. Pharm. 31 (2005) 249-256